Rezolute, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)

9 Months Ended

Mar. 31, 2023

Schedule of weighted average shares outstanding

Accordingly, the weighted average number of shares outstanding is computed as follows for the three and nine months ended March 31, 2023 and 2022 (in thousands):


	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2023		2022		2023		2022

Common Stock		36,827		15,557		36,531		12,735
2021 PFWs		1,661		1,661		1,661		1,013
2022 PFWs:
Class A PFWs		1,974		—		1,974		—
Class B PFWs		10,947		—		10,947		—
Total		51,409		17,218		51,113		13,748

Summary of potential common stock equivalents were excluded from the computation of diluted net loss per share

As of March 31, 2023 and 2022, the following outstanding potential common stock equivalents were excluded from the computation of diluted net loss per share since the impact of inclusion was anti-dilutive (in thousands):


	2023	2022

Stock options	8,779	1,590
Warrants	1,122	1,158
Total	9,901	2,748